Human Genomics

The sequencing, analysis and interpretation of the human genome, which leads to therapeutic, diagnostic and wellness applications.

LUX TAKE:

The costs of genomic sequencing continue to plunge at an exponential rate, which presents opportunities to unlock human genomic data at an unprecedented scale. The large aggregated genomic datasets enable the extraction of valuable information regarding which genetic variants contribute to biological function and disease. Growing evidence also indicates that different populations with the same ...

Lux Take last updated on August 23, 2021
Data last updated on January 21, 2022

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent human genomics developments.

News Commentaries

23andMe expands portfolio of approved cancer screenings with latest FDA approval (January 13, 2022)

Digital twin technology from Twin Health bags $140 million in Series C round for diabetes care (October 8, 2021)

New Lux Content

Inavya Ventures (January 21, 2022)

Identifying business opportunities to address the sustainability of Japan’s healthcare system (December 28, 2021)

Categories	Genomics, Genetics, Nutrigenomics, Artificial intelligence, Machine Learning, Diagnostics, Device-based therapeutics
Related companies	Oxford Nanopore Technologies, Oasis Diagnostics, Cambrian Genomics, Trana Discovery, Nutrigenomix, BiogeniQ, NextGen Jane, Ontera, iCarbonX, Verge Genomics, Advanced Genomic Solutions, 20/20 Gene Systems, NovogeneAIT Genomics, Helix Genomics, Nanopore Diagnostics, Pendulum Therapeutics, Biomeme, Nebula Genomics, X-Zell, SOPHiA Genetics, LifeNome, Genomics PLC

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978